A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint BlockadeLivnat Jerby‐Arnon, Charles H. Yoon, Parin Shah et al.|Cell|2018Cited by 1.5k
Activation of Tumor-Cell STING Primes NK-Cell TherapyErik H. Knelson, David A. Barbie, Elena V. Ivanova et al.|Cancer Immunology Research|2022Cited by 88
Tumor-Derived cGAMP Regulates Activation of the VasculatureMarco Campisi, David A. Barbie, Shriram K. Sundararaman et al.|Frontiers in Immunology|2020Cited by 61
MET-Induced CD73 Restrains STING-Mediated Immunogenicity of EGFR-Mutant Lung CancerRyohei Yoshida, David A. Barbie, Maria Saigí et al.|Cancer Research|2022Cited by 38
Targeting TREX1 Induces Innate Immune Response in Drug-Resistant Small-Cell Lung CancerTakahiko Murayama, Israel Cañadas, Elena V. Ivanova et al.|Cancer Research Communications|2024Cited by 26